KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company (“Provectus”), announced today that Dr. Sanjiv Agarwala of St. Luke’s Cancer Center will present data on its investigational new drug PV-10 for the treatment of melanoma at the III Eurasian Melanoma and Skin Cancers Forum, in Suzdal, Russia.
Dr. Agarwala’s presentation, titled “Intralesional Therapy: Focus on PV-10,” is scheduled to take place on Sunday, October 12, 2014 from 12:15-12:40 pm local time [GMT +04:00]. The Forum itself will run October 10-12, 2014 and is organized by the Eurasian Federation of Oncology.
Help employers find you! Check out all the jobs and post your resume.
